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Abstract
Infections as a result of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) are an issue of increasing global
healthcare concern. In Europe, this principally involves strains of multi-locus sequence type clonal complex 80 sequence type 80 with
methicillin resistance in a staphylococcal chromosomal cassette (SCCmec) type IV arrangement (CC80:ST80-IV). As with other CA-MRSA
strains, CC80:ST80-IV isolates tend to appear uniform when analysed by common molecular typing methods (e.g. pulsed ﬁeld gel electro-
phoresis, multi-locus sequence type, SCCmec). To explore whether DNA sequence-based differences exist, we compared the genetic
composition of six CC80:ST80-IV isolates of diverse chronological and geographic origin (i.e. Denmark and the Middle East) using an
Affymetrix high-density microarray that was previously used to analyse CA-MRSA USA300 isolates. The results revealed a high degree of
homology despite the diversity in isolation date and origin, with isolate differences primarily in conserved hypothetical open reading
frames and intergenic sequences, but also including regions of known function. This included the conﬁrmed loss of SCCmec recombinase
genes in two Danish isolates representing potentially new SCCmec types. Microarray analysis grouped the six isolates into three
relatedness pairs, also identiﬁed by pulsed ﬁeld gel electrophoresis, which were consistent with both the clinical and molecular data.
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Introduction
Although healthcare-associated (HA) methicillin-resistant
Staphylococcus aureus (MRSA) have been a subject of long-
standing clinical concern, infections as a result of community-
associated (CA) MRSA have now become an intense focus of
interest and investigation [1–3]. Although CA-MRSA are
globally distributed, speciﬁc strains continue to exhibit geo-
graphic predominance. In the USA, this is typiﬁed by isolates
that are multi-locus sequence type (MLST) clonal complex 8,
sequence type 8, staphylococcal cassette chromosome
(SCCmec) type IV (CC8:ST8-IV), exhibiting the USA300
pulsed-ﬁeld gel electrophoresis (PFGE) proﬁle [4,5]. In Eur-
ope, the most common CA-MRSA strain is CC80:ST80-IV
[6,7]. In Denmark, CC80:ST80-IV isolates are the predomi-
nant cause of CA-MRSA infections, with epidemiological
studies [7,8] showing a large proportion of patients with
family relationships in the Middle East. Individuals colonized
when traveling abroad or visiting such high endemic areas
have been suspected as likely sources of CC80:ST80-IV
importation because the overall proportion of MRSA in Den-
mark is very low (approximately 0.1%) [7,9]. However,
establishing direct transmission routes is challenging because
of the conserved nature of CC80:ST80-IV genomic (e.g.
PFGE) proﬁles [7], similar to other CA-MRSA, such as
USA300 [4,10]. Although at least 17 PFGE subtypes have
been identiﬁed in the Danish CC80:ST80-IV collection, there
has been no speciﬁc association between speciﬁc subtypes
and infections acquired domestically vs. those most likely
acquired abroad [7]. Concern regarding the increased inci-
dence of infections as a result of CA-MRSA has prompted
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investigations regarding their genetic composition, to better
understand their potential for virulence and epidemic spread.
In this context, microarrays have been a powerful tool for
assessing the genomic presence or absence of important loci
(e.g. regulatory, resistance, virulence or adhesion). For exam-
ple, analysis of USA300 (ST8) in comparison to CA-MRSA
USA400 (ST1) and HA-MRSA USA100 (ST5) and 500 (ST8)
using a high-density microarray (i.e. 7775 loci) revealed a
high degree of relatedness, especially between USA300 and
USA500, with a set of 20 known or hypothetical genes
unique to USA300 [4].
Past microarray analysis of CC80:ST80-IV by Monecke
et al. [11,12] used 100 and 87 probes, respectively (e.g. genes
for resistance and virulence) to compare isolates (12 from
Germany, ﬁve from the UK and two from Switzerland) with
a variety of S. aureus strains encoding the Panton–Valentine
leukocidin (PVL), including the sequenced S. aureus USA400
strain MW2. These analyses revealed a diverse origin for
pandemic PVL-positive strains but differences between
CC80:ST80-IV isolates in only four plasmid-born antibiotic-
resistance loci. Similarly, a recent study by Monecke et al.
[13] comparing eight German CC80:ST80-IV isolates using
157 probes for resistance and virulence revealed differences
only for plasmid-associated antibiotic resistance genes.
The S. aureus Affymetrix high-density microarray repre-
sents a powerful tool for genomic comparison because the
7775 loci include not only resistance determinants, toxins,
virulence regulators and cell surface factors, but also hypo-
thetical genes and intergenic sequences from the published
S. aureus N315, Mu50, COL and NCTC8325 genomes [4,14].
Sung et al. [15] noted the importance of mobile genetic ele-
ments (e.g. plasmids, transposable elements and bacterio-
phages) in strain differentiation. In addition, as our
understanding of microbial genomic organization, gene struc-
ture and function increases, sequences initially considered
to be unimportant are ﬁnding new signiﬁcance (e.g. phenol-
soluble modulins) [16,17]. Thus, the present study aimed to
use the S. aureus Affymetrix high-density microarray to inves-
tigate inter-relationships between six CC80:ST80-IV isolates
obtained from 1997–2003, including one of the earliest (i.e.
‘ancestral’) entries in the Danish database, as well as isolates
with possible ties to the Middle East (Lebanon and Egypt).
Materials and Methods
Bacterial isolates and susceptibility testing
Subsequent to 1988, Danish regional clinical microbiology
departments have systematically referred all MRSA isolates
to Statens Serum Institut. Based on hospital discharge sum-
maries or notes from outpatient clinics and physicians, all
patients with MRSA infections were evaluated for the poten-
tial origin of infection according to previously described cri-
teria [9,18]. A total of 294 CC80:ST80-IV cases were
registered (1988–2004), most of which were CA originating
in Denmark. However, a large proportion of cases had family
relationships in the Middle East [7]. For array investigation,
six isolates spanning a 6-year period were chosen including
an isolate from a patient infected during hospitalization in
Egypt and one from a patient born in Lebanon. Four isolates
caused CA infections (1198, 1200, 1202 and 1209) and one
caused a health care-associated community-onset infection
(1201). The remaining isolate (1199) was a surveillance cul-
ture (1199) from a patient transferred to Denmark from an
Egyptian hospital with no record of earlier hospitalization for
approximately 2 years. The isolates were unrelated as deter-
mined by epidemiological information. Susceptibility to cefox-
itin, penicillin, streptomycin, tetracycline, erythromycin,
clindamycin, fusidic acid, norﬂoxacin, kanamycin, rifampicin
and linezolid was assessed using Neosensitabs (Rosco,
Taastrup, Denmark) on Danish Blood agar (SSI, Copenhagen,
Denmark) [9]. Suspected methicillin/oxacillin resistance, pre-
dicted by cefoxitin test results, and fusidic acid resistance,
was conﬁrmed by detecting the mecA and fusB genes, respec-
tively [19,20].
PFGE and PCR
Molecular characterization by PFGE and PCR analysis for the
presence of the PVL genes, protein A gene (spa), accessory
global regulator (agr), SCCmec and MLST were performed as
described previously [7]. SCCmec typing was primarily con-
ducted using the multiplex PCR method of Oliveira and de
Lencastre [19] with additional ccr recombinase and mec typ-
ing as outlined by Kondo et al. [21] and Milheirico [22] .
Microarray analysis
The S. aureus CC80:ST80-IV isolates were analysed using a
commercially available S. aureus Affymetrix GeneChip
(Affymetrix, Santa Clara, CA, USA) as described previously
[4,14]. Chromosomal DNA was interrogated for the pres-
ence or absence of the 7775 loci on the GeneChip, which
included resistance determinants, exoenzymes, exo- or
enterotoxins and a variety of virulence regulators and cell
surface factors from the S. aureus N315, Mu50, COL and
NCTC8325 published genomes. Chromosomal DNA was
puriﬁed from each of the CC80:ST80-IV isolates, fragmented,
and biotinylated at the 3¢ end [4,14]. Labelled DNA (1.5 lg)
was hybridized to a GeneChip and adjusted ‘present’ and
‘absent’ determinations were made for each array locus with
an average of 20 probe sets per open reading frame (ORF)
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or intergenic region [4,14]. For adjusted calls, raw values
were log transformed and normalized by dividing each value
by the chip mean. Cut-off values for p calls were
£0.89 = absent; ‡0.981 = present; and 0.9–0.98 = marginal.
Results
As shown in Table 1, the CC80:ST80-IV isolates were pri-
marily associated with skin and soft tissue infections and
were chosen to represent differences in year of isolation,
potential geographic origin and antimicrobial susceptibility.
Initial genotypic characterization (Fig. 1) revealed the
expected homogeneity for spa, MLST, SCCmec (see below),
PVL and agr type. Minor variations (>90% similarity) in PFGE
patterns were consistent with published CC80:ST80-IV pro-
ﬁles. However, PFGE identiﬁed three subgroup pairs
(approximately 96% relatedness) that linked the two Middle
East isolates (1199 and 1200) cultured in 2001, Danish iso-
lates 1201 and 1202 (cultured in 2003 and 2001, respec-
tively) and Danish isolates 1198 and 1209, which were
isolated in 1997 (i.e, one of the earliest CC80:ST80-IV in the
database) and 2001, respectively.
Overall, when analysed on the S. aureus Affymetrix Gene-
Chip, DNA from the isolates hybridized to an average of
58% of the 7775 loci (i.e. 4489 ± 174). As shown in Fig. 2,
although 95% related, the isolates appeared to group in pairs
(i.e. 1199/1200, 1201/1202 and 1198/1209) similar to that
seen by PFGE. Differences were primarily in conserved hypo-
thetical ORFs and intergenic sequences as seen by pairwise
analysis (Table 2), indicating the number of the 7775 queried
loci present in one isolate but absent from another. This
comparison conﬁrmed that isolates 1199 and 1200 were the
most similar, with only 73 instances (18 plus 55) where a
locus found in one isolate was absent from the other. Isolate
pairs 1201/1202 and 1198/1209 had 354 and 326 instances of
nonshared loci, respectively. The inter-relationships were
even more clearly seen with intergenic sequences removed
from the analysis. As shown in Table 2, isolate pairs 1199/
1200 shared all remaining 3514 ORFs, followed by isolate
pair 1198/1209 with only 15 instances of nonshared loci. Iso-
late pair 1201 /1202 was more distantly related but lacked
the SCCmec-associated recombinase (ccr) genes but retained
mecA (see below).
A summary of differences between the CC80:ST80-IV iso-
lates (not including intergenic regions) is shown for 82 repre-
sentative loci in Table 3. In many instances, these appeared
to relate to variation in bacteriophage carriage. For example,
the isolates were identical for 20 of 21 probes associated
with PVL-encoding bacteriophages, with most being similar
to the Mu50 array sequences. However, only 1198 and 1209
contained the bacteriophage-associated SA1789 sequence.
Isolate 1198 contained at least one bacteriophage and vari-
ous hypothetical genes not found in isolates 1199 and 1200.
Isolate 1198 did not contain the epidermin immunity factor
(epiG) gene or hypothetical protein SA0848, found in all
other isolates. Isolate 1201 lacked hypothetical protein
SA0406, the SAA0001 replication initiation protein repC, the
TABLE 1. CC80:ST80-IV isolates examined
Isolate
number
Year of
isolation
Presumed country
of origin
Age of
patient
(years) Infection/screeninga
Antibiotic
resistance
patternb
1198 1997 Denmark 21 Skin and soft tissue infection (CA) Ox, P, K, F
1199 2001 Egypt 43 Screening in Denmark after heart attack abroad (S) Ox, P, S, T, K, F
1200 2001 Lebanon 5 Scratches infected during vacation in Lebanon (CA) Ox, P, S, T, K, F
1201 2003 Denmark 20 Folliculitis at thigh, knee, and eyelid (HACO) Ox, P, T, E, Cli, F
1202 2001 Denmark 19 Inﬂammation in axilla (CA) Ox, P, T, F
1209 2001 Denmark 10 Skin abscesses (CA) Ox, P, S, T, K, F
aCA, community-associated; S, surveillance; HACO, healthcare-associated community-onset.
bantibiotic resistance detected against: Ox, oxacillin; P, penicillin; S, streptomycin; T, tetracycline; E, erythromycin; Cli, clindamycin; F, fusidic acid; K, kanamycin.
FIG. 1. A summary of CC80:ST80-IV isolate
molecular characteristics by pulsed-ﬁeld gel
electrophoresis (PFGE) and analysis by PCR
for spa, MLST, SCCmec, pvl, and agr.
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SA0002 tetracycline resistance protein, the SAA0003 plasmid
recombination-mobilization protein pre, and uniquely con-
tained hypothetical protein SA2487. Isolate 1202 contained a
unique set of bacteriophage-associated adjacent genes (COL
SA1573–1586) encoding replication protein, integrase and
various hypothetical ORFs. Isolate 1209, most similar to iso-
late 1198, was unique in lacking virulence genes sdrD and
sdrE and hypothetical proteins SA0397, SA0753 and SA1346.
As noted above, although initially characterized as SCCmec
IV based on the Oliveira and de Lencastre multiplex PCR
protocol [19], further SCCmec subtyping using the strategy
of Kondo et al. [21] and Milheirico [22] revealed that isolates
1201 and 1202 lacked the SCCmec recombinase (ccr),
whereas all isolates contained the SCCmec IVc J1 sequence
(data not shown). All isolates were positive for mecA,
4mecR1, and YIS1272 SCCmec IV probes. Within loci that
varied among the CC80:ST80-IV (Table 4), the unique adja-
cent genes (COL SA1573-1586) in isolate 1202, as men-
tioned above, were also found in USA300 (CC8:ST8-IV). Of
the 57 most variable loci (i.e. either present or absent in
two to three of the six isolates), the majority (37/57; 65%)
were absent in both USA300 and USA400 (Table 3) [4]. For
loci of known function, CC80:ST80-IV isolates were generally
similar to USA300 and USA400. However, for 19 loci of
known function that varied between USA300 and USA400
[4], the CC80:ST80-IV isolates were more similar to
USA400. These differences included agr, capsule type, the
presence in USA300 of a complete ebh gene, fosfomycin
resistance, and assorted extracellular virulence determinants
(e.g. exotoxin 3) not found in USA400 or CC80:ST80-IV
(data not shown).
Discussion
As noted above, CA-MRSA strains are generally character-
ized by phenotypic and genotypic homogeneity which, cou-
pled with their ability to spread, complicates the
epidemiological picture. Currently, there is no accurate way
to determine whether the multiple isolates that one wishes
to compare represent the spread of a single or limited num-
ber of organisms vs. introduction from multiple independent
sources. This dilemma is potentially more problematic with a
higher MRSA prevalence. Because Denmark represents an
FIG. 2. Dendrogram (top) with heat map (beneath) for all loci that
were analysed in each isolate. The dendrogram illustrates relatedness
based on the signal intensity of each locus across all isolates. Within
the heat map, each locus (total = 7775) is shown vertically for each
strain. Red indicates high signal intensity; yellow indicates marginal
signal intensity, and blue indicates low signal intensity. The order of
loci is identical for all strains. For adjusted calls, raw values were log
transformed and normalized by dividing each value by the chip mean.
Cut-off values for p calls were £0.89 = absent; ‡0.981 = present;
and 0.9–0.98 = marginal. Asterisks indicate isolates that especially
clustered together by pairwise comparison (Table 2).
TABLE 2. Pairwise comparison of CC80:ST80-IV isolates for the number of 7775 queried loci and the 3514 open reading
frames (total loci minus intergenic sequences; shown in parentheses) that were present in one isolate but absent from
another
Loci absent
Loci present
1199 1200 1202 1201 1198 1209
1199 0 (0) 55 (0) 63 (16) 99 (3) 145 (47) 142 (46)
1200 18 (0) 0 (0) 44 (17) 80 (3) 125 (47) 130 (44)
1202 65 (11) 79 (11) 0 (0) 79 (3) 145 (59) 146 (58)
1201 275 (22) 337 (22) 275 (23) 0 (0) 206 (64) 211 (63)
1198 366 (17) 449 (17) 383 (28) 239 (10) 0 (0) 175 (7)
1209 364 (18) 425 (19) 364 (38) 204 (10) 151 (8) 0 (0)
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TABLE 3. GeneChip loci which varied between the CC80:ST80-IV isolates
Genes ORF no. Descriptiona
Results for:
Comments1198 1199 1200 1201 1202 1209
MW1419 Conserved hypothetical protein (MSSA476, MRSA252, MW2) + ) ) ) ) + USA300) USA400)
SAR395a Conserved hypothetical protein (MRSA252) ) + + + + ) USA300+ USA400)
SAV0876 Conserved hypothetical protein similar to phage
phi ETA protein (MU50)
+ ) ) ) ) + USA300) USA400+
SAV0880 Hypothetical protein (MU50) + ) ) ) ) + USA300) USA400)
SAV0884 Phage phi 11-like int gene activator protein (MU50) + ) ) ) ) + USA300) USA400)
SAV0884 Phage phi 11-like int gene activator protein (MU50) ) ) ) ) ) ) USA300) USA400)
SAV0885 Phage phi 11-like terminase protein (MU50) + ) ) ) ) + USA300) USA400)
SAV0886 Similar to phage terminase large subunit (MU50) + ) ) ) ) + USA300) USA400)
SAV0887 Phage phi MU50B/phi11-like portal protein (MU50) + ) ) ) ) + USA300) USA400)
SAV0888 Phage phi MU50B/phi11-like head protein (MU50) + ) ) ) ) + USA300) USA400)
SAV0890 Hypothetical phage phi MU50B/phi11-like protein (MU50) ) ) ) ) ) ) USA300) USA400)
SAV0890 Hypothetical phage phi MU50B/phi11-like protein (MU50) + ) ) ) ) + USA300) USA400)
SAV0891 Hypothetical phage phi11 head protein (MU50) + ) ) ) ) + USA300) USA400)
SAV0892 Phage phi MU50B/phi11-like head protein (MU50) + ) ) ) ) + USA300) USA400)
SAV0893 Phage phi MU50B/phi11-like protein (MU50) + ) ) ) ) + USA300) USA400)
SAV0894 Phage phi MU50B/phi11-like protein (MU50) + ) ) ) ) + USA300) USA400)
SAV0896 Phage phi MU50B/phi11-like protein (MU50) + ) ) ) ) + USA300) USA400)
SAV0897 Phage phi MU50B/phi11-like protein (MU50) + ) ) ) ) + USA300) USA400)
SAV0898 Similar to phage phi MU50 tail protein (MU50) + ) ) ) ) + USA300) USA400)
SAV0899 Hypothetical phage phi11 protein (MU50) + ) ) ) ) + USA300) USA400)
SAV0900 Hypothetical phage phi 11 protein (MU50) + ) ) ) ) + USA300) USA400)
SAV0901 Hypothetical phage minor tail subunit protein (MU50) + ) ) ) ) + USA300) USA400)
SAV0902 Conserved phi ETA orf 54-like protein (Mu50) + ) ) ) ) + USA300) USA400)
SAV0903 Conserved phi ETA orf 55-like protein (Mu50) + ) ) ) ) + USA300) USA400)
SAV0904 phi ETA orf 56-like protein (Mu50) + ) ) ) ) + USA300) USA400)
SAV0905 phiETA ORF57-like protein (Mu50) + ) ) ) ) + USA300) USA400)
SAV0906 phiETA ORF58-like protein (Mu50) + ) ) ) ) + USA300) USA400)
SAV0907 Conserved phage phiETA ORF59-like protein (Mu50) + ) ) ) ) + USA300) USA400)
SAV0909 Phage phi11 cell wall hydrolyase (MU50) + ) ) ) ) + USA300) USA400)
SAV0910 Phage phi11 tail ﬁber (MU50) + ) ) ) ) + USA300) USA400)
SAV0913 Amidase (MU50) + ) ) ) ) + USA300) USA400)
SAV1977 phi PV83-like protein (Mu50) + ) ) ) ) + USA300+ USA400)
SAS1087 Conserved hypothetical protein (MSSA476) ) + + + + ) USA300+ USA400+
SA0043 Hypothetical protein pathogenicity island SaPIn1 + + + ) ) + USA300+ USA400+
SA0044 Conserved hypothetical protein + + + ) ) + USA300) USA400)
SA0022 Hypothetical protein (N315) + ) ) + ) + USA300) USA400)
ccrB SA0057 Cassette chromosome recombinase B (N315) + + + ) ) + USA300+ USA400+
ccrA SA0058 Cassette chromosome recombinase A (N315) + + + ) ) + USA300+ USA400+
SA0059 Putative membrane protein (N315) + + + ) ) + USA300+ USA400+
SA0061 Hypothetical protein (N315) + + + ) ) + USA300) USA400)
SA1591 Arsenical resistance operon repressor homologue (N315) + ) ) ) ) + USA300) USA400)
SA0321 Prophage L54a, Cro-related protein + ) ) ) ) + USA300) USA400)
SA0322 Putative prophage L54a repressor protein + ) ) ) ) + USA300) USA400)
SA0331 Hypothetical protein ) + + ) + ) USA300) USA400)
SA0359 Hypothetical protein + ) ) ) ) + USA300) USA400)
SA0360 Conserved hypothetical protein + ) ) ) ) + USA300) USA400)
SA0397 Conserved hypothetical protein + + + + + ) USA300) USA400)
SA0406 Hypothetical protein + + + ) + + USA300+ USA400)
sdrD SA0520 Virulence gene (N315) + + + + + ) USA300+ USA400+
sdrE SA0610 Virulence gene + + + + + ) USA300+ USA400+
SA0753 Conserved hypothetical protein + + + + + ) USA300+ USA400+
SA0848 Hypothetical protein ) + + + + + USA300+ USA400)
SA0865 Hypothetical protein ) + + ) + ) USA300+ USA400+
SA0871 Putatative acetyltransferase ) + + ) + ) USA300+ USA400+
SA0881 Putative thioredoxin ) + + + + ) USA300+ USA400+
SA0984 Conserved hypothetical protein ) + + ) + ) USA300+ USA400+
SA1345 Hypothetical protein ) + + ) ) + USA300+ USA400)
SA1346 Conserved hypothetical protein + + + + + ) USA300+ USA400+
SA1527 Conserved hypothetical protein + ) ) + ) ) USA300+ USA400)
SA1573 Integrase/recombinase/transposase (phage) ) ) ) ) + ) USA300+ USA400)
SA1575 Hypothetical protein ) ) ) ) + ) USA300+ USA400)
SA1576 Hypothetical protein, similar to secretory antigen
precursor SsaA
) ) ) ) + ) USA300+ USA400)
SA1577 Conserved hypothetical protein ) ) ) ) + ) USA300+ USA400)
FtsK/SpoIIIE SA1578 Cell division protein ) ) ) ) + ) USA300+ USA400)
SA1579 Conserved putative conjugative transposon protein ) ) ) ) + ) USA300+ USA400)
SA1580 Hypothetical protein ) ) ) ) + ) USA300+ USA400)
SA1581 Conserved hypothetical protein ) ) ) ) + ) USA300+ USA400)
SA1582 Conserved hypothetical protein ) ) ) ) + ) USA300+ USA400)
SA1583 Replication initiation protein (transposon) ) ) ) ) + ) USA300+ USA400)
SA1584 Hypothetical protein ) ) ) ) + ) USA300+ USA400)
SA1585 Conserved hypothetical protein ) ) ) ) + ) USA300+ USA400)
SA1586 Hypothetical protein ) ) ) ) + ) USA300+ USA400)
SA1598 Conserved hypothetical protein (competence) ) + + ) + ) USA300+ USA400+
SA1789 Hypothetical protein phage phi PVL + ) ) ) ) + USA300) USA400)
SA1829 Hypothetical protein ) + + ) + ) USA300+ USA400+
SA1839 IS200-like transposase ) + + ) + ) USA300+ USA400+
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environment of low MRSA prevalence, we were interested
in comparatively analysing CC80:ST80-IV isolates chosen to
represent different years of isolation and the probability of
different geographic origin.
Although genetic exchange is known to occur between
S. aureus strains, the high degree of genomic relatedness
(95%) among the CC80:ST80-IV examined in the present
study supports a model of clonal expansion leading to geno-
mic uniformity, despite differences in time and geography.
However, upon closer examination, subtle differences were
observed, leading to potentially interesting ‘sub-type’ inter-
relationships. For example, the most similar isolates were
from outside of Denmark (1199 and 1200), both cultured in
2001 but from different locations (i.e. Lebanon and Egypt).
Because of the small number of isolates examined, it is
unclear whether clustering of the Lebanese and Egyptian iso-
lates apart from the isolates of Danish origin is signiﬁcant, as
are the conclusions regarding possible transmission from the
Middle East to Denmark. However, CC80:ST80-IV was
recently shown to constitute 55% of all MRSA in a large hos-
pital in Lebanon, which may support this hypothesis (Tokaj-
ian, et al., 13th International Symposium on Staphylococci
and Staphylococcal Infections, 2008, abstract P655). In addi-
tion, Denmark is a country of low MRSA endemicity
(approximately 0.1%) [23], with only a single case of
CC80:ST80-IV hospital transmission being documented to
date [7]. Therefore, the acquisition of MRSA in these two
patients before leaving Denmark for Lebanon and Egypt
would appear to be unlikely. Interesting inter-relationships
were also noted among the Danish isolates. Although cul-
tured over a 4-year time span (1997 vs. 2001), isolates 1198
and 1209 were the second most highly related pair. The ﬁnal
pair of isolates (1201 and 1202), found in Denmark over a
2-year period, were somewhat more distantly related but
shared the interesting loss of SCCmec-associated recombin-
ase genes at the same times as retaining mecA, DmecR1 and
YIS1272, and the SCCmec IVc speciﬁc J1 region. Recent
studies have reported both S. aureus [24] and Staphylococcus
epidermidis [25] isolates positive for mecA but negative for ccr
by PCR analysis. However, whether this is a result of the
absence of ccr or sequence divergence inﬂuencing primer
recognition remains unknown. Thus, to our knowledge, this
is the ﬁrst report of such a deletion that would clearly affect
the mobility/excision of SCCmec in these isolates. The multi-
year observation of these isolates suggests that they may
represent a stable CC80:ST80-IV subpopulation (e.g. a
SCCmec IV variant or potentially new type), the frequency
and signiﬁcance of which is currently unknown. Regarding
PVL, two recent studies [26,27] reported interesting
sequence differences related to speciﬁc MRSA strains and
geography. Microarray analysis indicated that all six
CC80:ST80-IV isolates appeared to carry the same PVL-asso-
ciated bacteriophage, similar to that of S. aureus strain Mu50.
As with issues related to SCCmec differences, additional
sequence-based studies of PVL could provide potentially
interesting information regarding possible isolate sub-type
inter-relationships.
It is reassuring to note that both PFGE and microarray
analysis identiﬁed the same relatedness pairs, which ﬁt well
with the overall clinical and molecular data, grouping the
Middle East and ccr-deleted pairs from the remaining Danish
isolates. This suggests that minor differences in both PFGE
and microarray analysis of genomically uniform strains such
as CC80:ST80-IV may have the potential for clinical and epi-
demiological signiﬁcance. However, conclusions regarding
these observations must be tempered by the small number
of isolates analysed. As with other CA-MRSA, the conserved
nature of CC80:ST80-IV isolates has limited the usefulness of
current molecular approaches for epidemiological investiga-
tion. Nevertheless, as with recent USA300 genomic analyses
[28,29], the data obtained in the present study suggest that
differences such as single-nucleotide polymorphisms and
divergence in hypothetical ORFs and intergenic regions may
ultimately provide a useful sequence-based foundation for
discerning epidemiologically meaningful inter-relationships.
This is further supported by the recently demonstrated
TABLE 3. (Continued)
Genes ORF no. Descriptiona
Results for:
Comments1198 1199 1200 1201 1202 1209
epiG SA1871 Epidermin immunity protein F ) + + + + + USA300+ USA400+
SA2307 Hypothetical protein ) + + ) + ) USA300+ USA400+
SA2327 Hypothetical protein (N315) ) + + + + ) USA300+ USA400+
SA2338 Hypothetical protein ) + + + + + USA300+ USA400+
SA2487 Conserved hypothetical protein ) ) ) + ) ) USA300+ USA400+
repC SAA0001 Replication initiation protein ) + + ) + + USA300+ USA400+
tetR SAA0002 Tetracycline resistance protein + + + ) + + USA300+ USA400+
pre SAA0003 Plasmid recombination/mobilization protein + + + ) + + USA300+ USA400+
aUnless otherwise noted, poen reading frame (ORF) numbers and descriptions refer to Staphylococcus aureus strain COL. Hypothetical proteins are sequences lacking a homo-
logue in the National Center for Biotechnology Information NR database; conserved hypothetical proteins have a homologue, although of no known function.
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ability of a small number of single-nucleotide polymorphisms
to provide meaningful typing data in the highly conserved
genomic background of Bacillus anthracis [30]. However, the
potential usefulness of microarray data for the epidemiological
analysis of CC80:ST80-IV clearly requires further evaluation
with isolates of known relatedness. Although microarray
analysis revealed differences between the CC80:ST80-IV iso-
lates primarily in conserved hypothetical ORFs and intergenic
sequences, these differences are worth noting because the
unknown function of such loci does not automatically equate
with unimportance. For example, approximately 80% of the
USA300 genome represents a coding sequence that includes
numerous conserved hypothetical proteins whose role is yet
to be determined [28]. In S. epidermidis, phenol-soluble mod-
ulins, now known to be important virulence factors [16],
were initially poorly annotated in genomic sequences [17].
Thus, sequence-based comparisons (i.e. differences and simi-
larities) of CA-MRSA strains such as CC80:ST80-IV hold
potential promise as a means of uncovering relevant and
important information that will hopefully lead to a better
understanding of both the pathogenicity and epidemiology of
these increasingly important pathogens.
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